Report Detail

Request for Sample of this report

Other Global AI Designed Antibodies Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4664935
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global AI Designed Antibodies market size was valued at US$ 422 million in 2025 and is forecast to a readjusted size of US$ 1932 million by 2032 with a CAGR of 24.2% during review period.
AI-designed antibodies refer to antibody discovery and engineering workflows that use machine learning/deep learning models to computationally generate, screen, and optimize antibody sequences and structures. By integrating antigen structure/epitope cues, antibody repertoire data, and experimental measurements (affinity, specificity, stability, immunogenicity, and developability), AI enables a closed loop of candidate generation, in silico ranking, multi-objective optimization, and wet-lab validation—accelerating the creation of improved antibody molecules and supporting tasks such as de novo design, affinity maturation, humanization, and developability risk reduction.
This report is a detailed and comprehensive analysis for global AI Designed Antibodies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Designed Antibodies market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Designed Antibodies market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Designed Antibodies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Designed Antibodies market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Designed Antibodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Designed Antibodies market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Generate:Biomedicines, Absci, Chai Discovery, Institute for Protein Design, Proteintech, AbCellera, LabGenius, Huashen, Tencent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Designed Antibodies market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bispecific Antibodies
Multispecific Antibodies
Market segment by Design Input
Structure-driven
Sequence-driven
Hybrid-driven
Market segment by Application
Biological Experiments
Drug Development
Others
Market segment by players, this report covers
Insilico Medicine
Generate:Biomedicines
Absci
Chai Discovery
Institute for Protein Design
Proteintech
AbCellera
LabGenius
Huashen
Tencent
Harbour BioMed
Dynegene Technologies
XtalPi
BioGeom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Designed Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Designed Antibodies, with revenue, gross margin, and global market share of AI Designed Antibodies from 2021 to 2026.
Chapter 3, the AI Designed Antibodies competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Designed Antibodies market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Designed Antibodies.
Chapter 13, to describe AI Designed Antibodies research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Designed Antibodies by Type
    • 1.3.1 Overview: Global AI Designed Antibodies Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Designed Antibodies Consumption Value Market Share by Type in 2025
    • 1.3.3 Bispecific Antibodies
    • 1.3.4 Multispecific Antibodies
  • 1.4 Classification of AI Designed Antibodies by Design Input
    • 1.4.1 Overview: Global AI Designed Antibodies Market Size by Design Input: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global AI Designed Antibodies Consumption Value Market Share by Design Input in 2025
    • 1.4.3 Structure-driven
    • 1.4.4 Sequence-driven
    • 1.4.5 Hybrid-driven
  • 1.5 Global AI Designed Antibodies Market by Application
    • 1.5.1 Overview: Global AI Designed Antibodies Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Biological Experiments
    • 1.5.3 Drug Development
    • 1.5.4 Others
  • 1.6 Global AI Designed Antibodies Market Size & Forecast
  • 1.7 Global AI Designed Antibodies Market Size and Forecast by Region
    • 1.7.1 Global AI Designed Antibodies Market Size by Region: 2021 VS 2025 VS 2032
    • 1.7.2 Global AI Designed Antibodies Market Size by Region, (2021-2032)
    • 1.7.3 North America AI Designed Antibodies Market Size and Prospect (2021-2032)
    • 1.7.4 Europe AI Designed Antibodies Market Size and Prospect (2021-2032)
    • 1.7.5 Asia-Pacific AI Designed Antibodies Market Size and Prospect (2021-2032)
    • 1.7.6 South America AI Designed Antibodies Market Size and Prospect (2021-2032)
    • 1.7.7 Middle East & Africa AI Designed Antibodies Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Insilico Medicine
    • 2.1.1 Insilico Medicine Details
    • 2.1.2 Insilico Medicine Major Business
    • 2.1.3 Insilico Medicine AI Designed Antibodies Product and Solutions
    • 2.1.4 Insilico Medicine AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Insilico Medicine Recent Developments and Future Plans
  • 2.2 Generate:Biomedicines
    • 2.2.1 Generate:Biomedicines Details
    • 2.2.2 Generate:Biomedicines Major Business
    • 2.2.3 Generate:Biomedicines AI Designed Antibodies Product and Solutions
    • 2.2.4 Generate:Biomedicines AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Generate:Biomedicines Recent Developments and Future Plans
  • 2.3 Absci
    • 2.3.1 Absci Details
    • 2.3.2 Absci Major Business
    • 2.3.3 Absci AI Designed Antibodies Product and Solutions
    • 2.3.4 Absci AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Absci Recent Developments and Future Plans
  • 2.4 Chai Discovery
    • 2.4.1 Chai Discovery Details
    • 2.4.2 Chai Discovery Major Business
    • 2.4.3 Chai Discovery AI Designed Antibodies Product and Solutions
    • 2.4.4 Chai Discovery AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Chai Discovery Recent Developments and Future Plans
  • 2.5 Institute for Protein Design
    • 2.5.1 Institute for Protein Design Details
    • 2.5.2 Institute for Protein Design Major Business
    • 2.5.3 Institute for Protein Design AI Designed Antibodies Product and Solutions
    • 2.5.4 Institute for Protein Design AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Institute for Protein Design Recent Developments and Future Plans
  • 2.6 Proteintech
    • 2.6.1 Proteintech Details
    • 2.6.2 Proteintech Major Business
    • 2.6.3 Proteintech AI Designed Antibodies Product and Solutions
    • 2.6.4 Proteintech AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Proteintech Recent Developments and Future Plans
  • 2.7 AbCellera
    • 2.7.1 AbCellera Details
    • 2.7.2 AbCellera Major Business
    • 2.7.3 AbCellera AI Designed Antibodies Product and Solutions
    • 2.7.4 AbCellera AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 AbCellera Recent Developments and Future Plans
  • 2.8 LabGenius
    • 2.8.1 LabGenius Details
    • 2.8.2 LabGenius Major Business
    • 2.8.3 LabGenius AI Designed Antibodies Product and Solutions
    • 2.8.4 LabGenius AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 LabGenius Recent Developments and Future Plans
  • 2.9 Huashen
    • 2.9.1 Huashen Details
    • 2.9.2 Huashen Major Business
    • 2.9.3 Huashen AI Designed Antibodies Product and Solutions
    • 2.9.4 Huashen AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Huashen Recent Developments and Future Plans
  • 2.10 Tencent
    • 2.10.1 Tencent Details
    • 2.10.2 Tencent Major Business
    • 2.10.3 Tencent AI Designed Antibodies Product and Solutions
    • 2.10.4 Tencent AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Tencent Recent Developments and Future Plans
  • 2.11 Harbour BioMed
    • 2.11.1 Harbour BioMed Details
    • 2.11.2 Harbour BioMed Major Business
    • 2.11.3 Harbour BioMed AI Designed Antibodies Product and Solutions
    • 2.11.4 Harbour BioMed AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Harbour BioMed Recent Developments and Future Plans
  • 2.12 Dynegene Technologies
    • 2.12.1 Dynegene Technologies Details
    • 2.12.2 Dynegene Technologies Major Business
    • 2.12.3 Dynegene Technologies AI Designed Antibodies Product and Solutions
    • 2.12.4 Dynegene Technologies AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Dynegene Technologies Recent Developments and Future Plans
  • 2.13 XtalPi
    • 2.13.1 XtalPi Details
    • 2.13.2 XtalPi Major Business
    • 2.13.3 XtalPi AI Designed Antibodies Product and Solutions
    • 2.13.4 XtalPi AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 XtalPi Recent Developments and Future Plans
  • 2.14 BioGeom
    • 2.14.1 BioGeom Details
    • 2.14.2 BioGeom Major Business
    • 2.14.3 BioGeom AI Designed Antibodies Product and Solutions
    • 2.14.4 BioGeom AI Designed Antibodies Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 BioGeom Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Designed Antibodies Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Designed Antibodies by Company Revenue
    • 3.2.2 Top 3 AI Designed Antibodies Players Market Share in 2025
    • 3.2.3 Top 6 AI Designed Antibodies Players Market Share in 2025
  • 3.3 AI Designed Antibodies Market: Overall Company Footprint Analysis
    • 3.3.1 AI Designed Antibodies Market: Region Footprint
    • 3.3.2 AI Designed Antibodies Market: Company Product Type Footprint
    • 3.3.3 AI Designed Antibodies Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Designed Antibodies Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Designed Antibodies Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Designed Antibodies Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Designed Antibodies Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Designed Antibodies Consumption Value by Type (2021-2032)
  • 6.2 North America AI Designed Antibodies Market Size by Application (2021-2032)
  • 6.3 North America AI Designed Antibodies Market Size by Country
    • 6.3.1 North America AI Designed Antibodies Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Designed Antibodies Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Designed Antibodies Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Designed Antibodies Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Designed Antibodies Market Size by Country
    • 7.3.1 Europe AI Designed Antibodies Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Designed Antibodies Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Designed Antibodies Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Designed Antibodies Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Designed Antibodies Market Size by Region
    • 8.3.1 Asia-Pacific AI Designed Antibodies Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Designed Antibodies Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Designed Antibodies Consumption Value by Type (2021-2032)
  • 9.2 South America AI Designed Antibodies Consumption Value by Application (2021-2032)
  • 9.3 South America AI Designed Antibodies Market Size by Country
    • 9.3.1 South America AI Designed Antibodies Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Designed Antibodies Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Designed Antibodies Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Designed Antibodies Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Designed Antibodies Market Size by Country
    • 10.3.1 Middle East & Africa AI Designed Antibodies Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Designed Antibodies Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Designed Antibodies Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Designed Antibodies Market Drivers
  • 11.2 AI Designed Antibodies Market Restraints
  • 11.3 AI Designed Antibodies Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Designed Antibodies Industry Chain
  • 12.2 AI Designed Antibodies Upstream Analysis
  • 12.3 AI Designed Antibodies Midstream Analysis
  • 12.4 AI Designed Antibodies Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI Designed Antibodies. Industry analysis & Market Report on AI Designed Antibodies is a syndicated market report, published as Global AI Designed Antibodies Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Designed Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo